Protein S assays: An analysis of North American specialized coagulation laboratory association proficiency testing

American Journal of Clinical Pathology

Volumn 123, Issue 5, 2005, Pages 778-785

  Van Cott, Elizabeth M ^a   Ledford Kraemer, Marlies ^b   Meijer, Piet ^c   Nichols, William L ^d   Johnson, Stephen M ^e   Peerschke, Ellinor I B ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CLOT ED   (United States)

^c ECAT Foundation   (Netherlands)

^d Mayo Clinic College of Medicine   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Proficiency testing; Protein S

Indexed keywords

PROTEIN S; REAGENT;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INSTRUMENT; LABORATORY TEST; NORTH AMERICA; PERFORMANCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN S DEFICIENCY; QUALITY CONTROL; RELIABILITY; STANDARDIZATION; VEIN THROMBOSIS;

BIOLOGICAL ASSAY; BLOOD COAGULATION; HUMANS; LABORATORIES; LABORATORY TECHNIQUES AND PROCEDURES; NORTH AMERICA; PATHOLOGY, CLINICAL; PROTEIN S;

EID: 17844392362     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/BG1G-R3AN-AR99-05F4     Document Type: Article

References (21)

1. Dykes AC, Walker ID, McMaon AD, et al. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001;113:636-641.
2. Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA project. Thromb Haemost. 1997;78:636-640.
3. Heijboer H, Brandjes DPM, Buller HR, et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 1990;323:1512-1516.
4. Melissari E, Monte G, Lindo VS, et al. Congenital thrombophilia among patients with venous thromboembolism. Biood Coagul Fibrinolysis. 1992;3:749-758.
5. Zoller B, Berntsdotter A, Garcia de Fruto P, et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85:3518-3523.
6. Simmonds RE, Ireland H, Lane DA, et al. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med. 1998;128:8-14.
7. Makris M, Leach M, Beauchamp NJ, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95:1935-1941.
8. Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92:2353-2358.
9. Faioni EM, Valsecchi C, Palla A, et al. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost. 1997;78:1343-1346.
10. van der Meer FJM, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997;78:631-635.
11. Gandrille S, Borgel D, Sala N, et al. Scientific and Standardization Committee Communication: protein S deficiency: a database of mutations: first update. 2000. Available at: http://www.med.unc.edu/isth/SSC/communications/ plasma_coagulation/proteins.htm. Accessed January 2005.
12. Meijer P, Kluft C, Haverkate F, et al. The long-term within- and between-laboratory variability for assay of antithrombin, proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation. J Thromb Haemost. 2003;1:748-753.
13. Jennings I, Kitchen S, Cooper P, et al. Sensitivity of functional protein S assays to protein S deficiency: a comparative study of three commercial kits. J Thromb Haemost. 2003;1:1112-1117.
14. Simmonds RE, Zoller B, Ireland H, et al. Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood. 1997;89:4364-4370.
15. Espinosa-Parrilla Y, Morell M, Souto JC, et al. Protein S gene analysis reveals the presence of a cosegregating mutation in most pedigrees with type I but not type III PS deficiency. Hum Mutat. 1999;14:30-39.
16. Espinosa-Parrilla Y, Navarro G, Morell M, et al. Homozygosity for the protein S Heerlen allele is associated with type I PS deficiency in a thrombophilic pedigree with multiple risk factors. Thromb Haemost. 2000;83:102-106.
17. Espinosa-Parrilla Y, Yamazaki T, Sala N, et al. Protein S secretion differences of missense mutants account for phenotypic heterogeneity. Blood. 2000;95:173-179.
18. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, et al. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349-1366.
19. Faioni EM, Franci F, Asti D, et al. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost. 1993;70:1067-1071.
20. D'Angelo SV, Mazzola G, Della Valle P, et al. Variable interference of activated protein C resistance in the measurement of protein S activity by commercial assays. Thromb Res. 1995;77:375-378.
21. Faioni EM, Boyer-Neumann C, Franchi F, et al. Another protein S functional assay is sensitive to resistance to activated protein C [letter]. Thromb Haemost. 1994;72:648.